Filing Details
- Accession Number:
- 0001127602-17-033974
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-12-05 17:47:59
- Reporting Period:
- 2017-12-01
- Accepted Time:
- 2017-12-05 17:47:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1110803 | Illumina Inc | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1642678 | Omead Ostadan | 5200 Illumina Way San Diego CA 92122 | Evp Ops, Products, Strategy | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-12-01 | 3,540 | $37.04 | 26,827 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-12-01 | 2,200 | $226.44 | 24,627 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-12-01 | 1,140 | $227.57 | 23,487 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-12-01 | 200 | $228.33 | 23,287 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2017-12-01 | 3,540 | $0.00 | 3,540 | $37.04 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2010-02-27 | 2020-01-27 | No | 4 | M | Direct |
Footnotes
- The sale was made pursuant to a 10b5-1 plan.
- Weighted average sale price representing 2,200 shares sold ranging from $226.10 to $227.04 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 1,140 shares sold ranging from $227.19 to $228.00 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 200 shares sold ranging from $228.23 to $228.42 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
Billionaire Hedge Funds
